In a recent press release, ThinkGenetic, Inc. announced the appointment of Ruth Jacob O’Keefe as its new Chief Executive Officer (CEO). This strategic decision underscores the company’s commitment to its core mission and marks a noteworthy milestone in its ongoing journey.
Len Barker, ThinkGenetic’s President and Co-founder, expressed his enthusiasm for this transition, saying, “We are thrilled to have Ruth take the helm as our new CEO. Her unbounded energy and seasoned leadership will play a vital role as we expand our impact, especially for the 30 million people living with a rare condition in the US.”
Ruth Jacob O’Keefe has been an integral part of ThinkGenetic since its inception in 2016, holding key roles within the organization. Her strategic, high-energy leadership style has earned her respect from both team members and clients alike.
Dave Jacob, ThinkGenetic co-founder, expressed his support of the promotion stating, “The decision to appoint Ruth as CEO comes with resounding support from the executive leadership team and the resolute backing of the Board of Directors. I believe this change aligns with ThinkGenetic’s ambitious plans while remaining steadfast in its mission to make a difference in the world of rare diseases.”
While Ruth’s promotion signifies a change in the executive structure, the ThinkGenetic team will remain intact. Len Barker will transition to the role of Chief Operating Officer (COO), and Dave Jacob, the current CEO, will continue to serve as an advisor and member of the board of directors.
Ruth, upon receiving the news, shared her excitement, saying, “I am deeply honored and excited to take on the role of CEO at ThinkGenetic. We have a talented and passionate team and we are poised to make an even greater impact on those struggling for an accurate diagnosis.”
Ruth’s role as CEO officially commenced on October 2, 2023, and she will work closely with ThinkGenetic’s leadership, board members, and investors to further the organization’s success in supporting pharmaceutical organizations, research institutions, and healthcare systems.